Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2005
08/03/2005CN1213045C Tyrosine kinase inhibitors
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213035C 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
08/03/2005CN1213031C Method for producing 5-aryl nicotinaldehydes
08/03/2005CN1213026C Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
08/02/2005US6924376 Compounds, compositions and methods
08/02/2005US6924330 Thioimidazolidine derivatives as light stabilizers for polymers
08/02/2005US6924302 Nitrogen compounds such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
08/02/2005US6924287 Respiratory syncytial virus replication inhibitors
08/02/2005US6924285 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
08/02/2005US6924284 PARP inhibitors
08/02/2005US6924281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
08/02/2005US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases
08/02/2005US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
08/02/2005CA2332538C Novel 4-phenylpiperidines for the treatment of pruritic dermatoses
08/02/2005CA2325358C 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b
08/02/2005CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/02/2005CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
07/2005
07/28/2005WO2005068468A2 Heterocyclic protein kinase inhibitors and uses thereof
07/28/2005WO2005068448A1 Sulfonamides antagonising n-type calcium channels
07/28/2005WO2005068437A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis
07/28/2005WO2005068436A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
07/28/2005WO2005067933A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system
07/28/2005WO2005067923A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
07/28/2005WO2005067502A2 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
07/28/2005WO2005048948A3 Urea derivatives as kinase modulators
07/28/2005WO2005033330A3 Fluorescent probes for use in protein kinase inhibitor binding assay
07/28/2005WO2002096905A8 Thiazole compounds useful as inhibitors of protein kinases
07/28/2005US20050165242 hydrolysis of atorvastatin lactone with sodium hydroxide to form atorvastatin sodium salt solution; addition to an aqueous calcium chloride or calcium acetate solution; andisolation by filtration and drying; scalable, cost-effective and robust process
07/28/2005US20050165074 inhibitors of protein tyrosine kinases, for preventing of cancer, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165063 Amine compounds and use thereof
07/28/2005US20050165058 Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla
07/28/2005US20050165053 Substituted4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof
07/28/2005US20050165052 combining substituted quinolines with a carrier; leishmania/HIV infection; viricide, parasiticide
07/28/2005US20050165051 Taxanes having a C7 carbonate substituent
07/28/2005US20050165050 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
07/28/2005US20050165049 2-(2,2,2-Trifluoro-ethyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxylic acid quinolin-7-ylamides; treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, arthritis, gastrointestinal disorders
07/28/2005US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide
07/28/2005US20050165042 Fused tricyclic heterocycles useful for treating hyper-proliferative disoroders
07/28/2005US20050165036 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
07/28/2005US20050165031 1-(4-(3-(Pyridin-4-yl)propoxy)phenyl)-3-(5-tert-butylisoxazol-3-yl)urea; inhibits protein tyrosine kinases or a specific kinase or kinase class; for for treating and preventing conditions and diseases such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
07/28/2005US20050165028 e.g. 4-bromo-N-(2,3-dihydro-1,4-benzodioxin-6-yl)benzamide; analgesics, neuropathic pain, inflammation, arthritis, rheumatic diseases, inflammatory bowel disorders, eye disorders, or bladder disorders, psoriasis, wounds, burns, allergic skin, herpes simplex
07/28/2005US20050165024 Urea derivatives as kinase modulators
07/28/2005US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
07/28/2005US20050165021 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
07/28/2005US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology
07/28/2005US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/28/2005US20050165007 Benzimidazoles and analogs thereof as antivirals
07/28/2005US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling
07/28/2005US20050165001 Quinazolinone and benzoxazinone derivatives and uses thereof
07/28/2005US20050164885 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
07/28/2005US20050164868 Non-heating clay composites for building materials
07/28/2005US20050163715 Dynamic organ function monitoring agents
07/28/2005CA2553200A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
07/28/2005CA2552953A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
07/28/2005CA2552681A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system
07/28/2005CA2551869A1 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
07/28/2005CA2551770A1 2, 4 - diaminopyrimidines and their use for inducing cardiomyogenesis
07/28/2005CA2547080A1 Heterocyclic protein kinase inhibitors and uses thereof
07/28/2005CA2456430A1 Improved process for the preparation of amorphous atorvastatin calcium
07/27/2005EP1557414A1 Isoquinoline compounds and medicinal use thereof
07/27/2005EP1557411A1 N-phenyl-(2r,5s)dimethylpiperadine derivative
07/27/2005EP1557410A2 Bacterial gyrase inhibitors and uses thereof
07/27/2005EP1556390A2 Functionalized ionic liquids, and methods of use thereof
07/27/2005EP1556379A2 Chemical compounds
07/27/2005EP1556376A1 Large conductance calcium-activated k channel opener
07/27/2005EP1556375A2 Flavone derivatives as inhibitors of cyclin-dependent kinases
07/27/2005EP1556374A2 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer
07/27/2005EP1556373A1 Cannabinoid receptor ligands and uses thereof
07/27/2005EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors
07/27/2005EP1556362A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
07/27/2005EP1556356A1 Tetrahydroquinoline derivatives as crth2 antagonists
07/27/2005EP1556349A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
07/27/2005EP1556348A1 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
07/27/2005EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof
07/27/2005EP1556346A1 1-phenylpyrrolidine-2-one-3-carboxamides
07/27/2005EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy
07/27/2005EP1556052A2 Mitotic kinesin inhibitors
07/27/2005EP1556049A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors
07/27/2005EP1556047A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases
07/27/2005EP1556035A2 Novel aromatic compounds possessing antifungal or antibacterial activity
07/27/2005EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
07/27/2005EP1318992B1 Imidazole derivatives as raf kinase inhibitors
07/27/2005EP1250335B1 Process and intermediates for the preparation of imidazopyridines
07/27/2005EP1133489B1 Isonipecotamides for the treatment of integrin-mediated disorders
07/27/2005EP0973705B1 Chromatographic enantiomer separation of lactones
07/27/2005CN1646540A Functionalized ionic liquids, and methods of use thereof
07/27/2005CN1646524A Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them
07/27/2005CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors
07/27/2005CN1646516A Imidazolinylmethyl aralkylsulfonamides
07/27/2005CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
07/27/2005CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators
07/27/2005CN1646495A Amine compounds and use thereof
07/27/2005CN1646490A Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms I, VIII and IX
07/27/2005CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles
07/27/2005CN1646446A Non-heating clay composites for building materials
07/27/2005CN1646141A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
07/26/2005US6921821 Antagonists of melanin concentrating hormone receptor